John H. Heiligenstein

4.4k total citations
48 papers, 3.4k citations indexed

About

John H. Heiligenstein is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, John H. Heiligenstein has authored 48 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Psychiatry and Mental health, 16 papers in Pharmacology and 15 papers in Clinical Psychology. Recurrent topics in John H. Heiligenstein's work include Attention Deficit Hyperactivity Disorder (20 papers), Treatment of Major Depression (16 papers) and Child and Adolescent Psychosocial and Emotional Development (10 papers). John H. Heiligenstein is often cited by papers focused on Attention Deficit Hyperactivity Disorder (20 papers), Treatment of Major Depression (16 papers) and Child and Adolescent Psychosocial and Emotional Development (10 papers). John H. Heiligenstein collaborates with scholars based in United States, Germany and United Kingdom. John H. Heiligenstein's co-authors include Douglas E. Faries, Joseph Biederman, Christopher J. Kratochvil, Thomas Spencer, S. Hoog, Jennie G. Jacobson, Mary Nilsson, Graham J. Emslie, Karen Dineen Wagner and Regina Dittmann and has published in prestigious journals such as Journal of the American Statistical Association, PEDIATRICS and Biological Psychiatry.

In The Last Decade

John H. Heiligenstein

47 papers receiving 3.2k citations

Peers

John H. Heiligenstein

PMH

PHARM

ECP

Ira D. Glick United States

Marcia G. Toprac United States

James W. Jefferson United States

Jules Rosen United States

Thomas Laughren United States

J.P. Lépine France

Ronald N. Marcus United States

William C. Wirshing United States

Katja Komossa Germany

Daniel J. Luchins United States

Ira D. Glick United States

John H. Heiligenstein

3.5k ×1.7

PMH

2.0k ×1.7

598 ×0.8

PHARM

321 ×0.5

378 ×0.8

ECP

Citations per year, relative to John H. Heiligenstein John H. Heiligenstein (= 1×) peers Ira D. Glick

Countries citing papers authored by John H. Heiligenstein

Since Specialization

Citations

This map shows the geographic impact of John H. Heiligenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Heiligenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Heiligenstein more than expected).

Fields of papers citing papers by John H. Heiligenstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John H. Heiligenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Heiligenstein. The network helps show where John H. Heiligenstein may publish in the future.

Co-authorship network of co-authors of John H. Heiligenstein

This figure shows the co-authorship network connecting the top 25 collaborators of John H. Heiligenstein. A scholar is included among the top collaborators of John H. Heiligenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John H. Heiligenstein. John H. Heiligenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Ying, Mary Nilsson, John H. Heiligenstein, Michael G. Wilson, & Graham J. Emslie. (2006). An Exploratory Factor Analysis of the Children’s Depression Rating Scale–Revised. Journal of Child and Adolescent Psychopharmacology. 16(4). 482–491. 27 indexed citations

Nilsson, Mary, et al.. (2004). Safety of Subchronic Treatment with Fluoxetine for Major Depressive Disorder in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology. 14(3). 412–417. 32 indexed citations

Vitiello, Benedetto, John H. Heiligenstein, Mark A. Riddle, Laurence L. Greenhill, & Jörg M. Fegert. (2004). The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration. Biological Psychiatry. 56(1). 3–9. 30 indexed citations

Emslie, Graham J., John H. Heiligenstein, S. Hoog, et al.. (2004). Fluoxetine Treatment for Prevention of Relapse of Depression in Children and Adolescents: A Double-Blind, Placebo-Controlled Study. Journal of the American Academy of Child & Adolescent Psychiatry. 43(11). 1397–1405. 102 indexed citations

Spencer, Thomas, John H. Heiligenstein, Joseph Biederman, et al.. (2002). Results From 2 Proof-of-Concept, Placebo-Controlled Studies of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder. The Journal of Clinical Psychiatry. 63(12). 1140–1147. 292 indexed citations

Emslie, Graham J., John H. Heiligenstein, Karen Dineen Wagner, et al.. (2002). Fluoxetine for Acute Treatment of Depression in Children and Adolescents: A Placebo-Controlled, Randomized Clinical Trial. Journal of the American Academy of Child & Adolescent Psychiatry. 41(10). 1205–1215. 427 indexed citations

Kratochvil, Christopher J., John H. Heiligenstein, Regina Dittmann, et al.. (2002). Atomoxetine and Methylphenidate Treatment in Children With ADHD: A Prospective, Randomized, Open-Label Trial. Journal of the American Academy of Child & Adolescent Psychiatry. 41(7). 776–784. 203 indexed citations

Faries, Douglas E., John H. Heiligenstein, G.D. Tollefson, & William Z. Potter. (2001). The Double-Blind Variable Placebo Lead-in Period: Results From Two Antidepressant Clinical Trials. Journal of Clinical Psychopharmacology. 21(6). 561–568. 60 indexed citations

Geller, Daniel, et al.. (2001). Fluoxetine Treatment for Obsessive-Compulsive Disorder in Children and Adolescents: A Placebo-Controlled Clinical Trial. Journal of the American Academy of Child & Adolescent Psychiatry. 40(7). 773–779. 203 indexed citations

10.

Simon, Gwendal, Dennis A. Revicki, John H. Heiligenstein, et al.. (2000). Recovery from depression, work productivity, and health care costs among primary care patients. General Hospital Psychiatry. 22(3). 153–162. 207 indexed citations

11.

Hylan, Timothy R., William H. Crown, Laurie Meneades, et al.. (1999). SSRI Antidepressant Drug Use Patterns in the Naturalistic Setting. Medical Care. 37(4 Suppl Lilly). AS36–AS44. 30 indexed citations

12.

Holland, Jimmie C., Steven J. Romano, John H. Heiligenstein, R. Tepner, & Michael G. Wilson. (1998). A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psycho-Oncology. 7(4). 291–300. 126 indexed citations

13.

Revicki, Dennis A., Cynthia S. Palmer, Scott Phillips, et al.. (1997). Acute Medical Costs of Fluoxetine versus Tricyclic Antidepressants. PharmacoEconomics. 11(1). 48–55. 16 indexed citations

14.

Hylan, Timothy R., James G. Kotsanos, John Sahl Andersen, et al.. (1996). Comparison of a Decision Analytic Model with Results from a Naturalistic Economic Clinical Trial: An Application to Evaluating Alternative Antidepressants. The American Journal of Managed Care. 2. 15 indexed citations

15.

Tollefson, G.D., et al.. (1996). Is there a relationship between baseline and treatment-associated changes in [H]-IMI platelet binding and clinical response in major depression?. Neuropsychopharmacology. 14(1). 47–53. 7 indexed citations

16.

Heiligenstein, John H., et al.. (1995). Acute Effects of Fluoxetine Versus. International Psychogeriatrics. 7. 125–137. 59 indexed citations

17.

Tollefson, Gary D., et al.. (1995). A Double-Blind, Placebo-Controlled Clinical Trial of Fluoxetine in Geriatric Patients With Major Depression. International Psychogeriatrics. 7(1). 89–104. 112 indexed citations

18.

Heiligenstein, John H., Gary D. Tollefson, & Douglas E. Faries. (1994). Response patterns of depressed outpatients with and without melancholia: a double-blind, placebo-controlled trial of fluoxetine versus placebo. Journal of Affective Disorders. 30(3). 163–173. 35 indexed citations

19.

Heiligenstein, John H., Douglas E. Faries, A. John Rush, et al.. (1994). Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients. Psychiatry Research. 52(3). 327–339. 24 indexed citations

20.

Heiligenstein, John H., Gary D. Tollefson, & Douglas E. Faries. (1993). A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia. International Clinical Psychopharmacology. 8(4). 247–252. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact